Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-23

Clinical Trial Update: Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting completed Phase 2/Phase 3 human laboratory study of varenicline and bupropion for nicotine dependence and withdrawal with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)
  • bupropion (bupropion)

Snippet

Sponsor: University of Minnesota | Conditions: Nicotine Dependence, Nicotine Withdrawal | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-11-23